Pro PG receives S19 A for Bleomycin Injection (market shortage Australia) - stock available now.

​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.

Bleomycin Injection is currently experiencing a shortage of supply in Australia.

Product: Bleomycin Injection 15 Units S19a

Stock availability: Stock is available now at Wholesalers Nationally.


Orders can be placed via Wholesalers Symbion and Central Healthcare Services (CHS) via the below PDE numbers.

Symbion PDE: 629103


Please click for Dear Health Care Professional Letter

Please click to see Product Information for Health Professionals

Recent Posts
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Pro PG and Logo are registered trademarks (EU, UK, Australia)  owned by Pro Pharmaceuticals Group

VAT: NL825524295B01

VAT: PL5263362401

ABN: 20605457430